Global Tofacitinib Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Tofacitinib Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Tofacitinib by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Tofacitinib by Country/Region, 2017, 2022 & 2028

2.2 Tofacitinib Segment by Type

2.2.1 5mg*60 Tablets

2.2.2 5mg*10 Tablets

2.2.3 10mg*10 Tablets

2.2.4 5mg*30 Tablets

2.2.5 5mg*14 Tablets

2.2.6 10mg*14 Tablets

2.3 Tofacitinib Sales by Type

2.3.1 Global Tofacitinib Sales Market Share by Type (2017-2022)

2.3.2 Global Tofacitinib Revenue and Market Share by Type (2017-2022)

2.3.3 Global Tofacitinib Sale Price by Type (2017-2022)

2.4 Tofacitinib Segment by Application

2.4.1 Rheumatoid Arthritis

2.4.2 Ulcerative Colitis

2.4.3 Psoriasis

2.4.4 Other

2.5 Tofacitinib Sales by Application

2.5.1 Global Tofacitinib Sale Market Share by Application (2017-2022)

2.5.2 Global Tofacitinib Revenue and Market Share by Application (2017-2022)

2.5.3 Global Tofacitinib Sale Price by Application (2017-2022)

3 Global Tofacitinib by Company

3.1 Global Tofacitinib Breakdown Data by Company

3.1.1 Global Tofacitinib Annual Sales by Company (2020-2022)

3.1.2 Global Tofacitinib Sales Market Share by Company (2020-2022)

3.2 Global Tofacitinib Annual Revenue by Company (2020-2022)

3.2.1 Global Tofacitinib Revenue by Company (2020-2022)

3.2.2 Global Tofacitinib Revenue Market Share by Company (2020-2022)

3.3 Global Tofacitinib Sale Price by Company

3.4 Key Manufacturers Tofacitinib Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Tofacitinib Product Location Distribution

3.4.2 Players Tofacitinib Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Tofacitinib by Geographic Region

4.1 World Historic Tofacitinib Market Size by Geographic Region (2017-2022)

4.1.1 Global Tofacitinib Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Tofacitinib Annual Revenue by Geographic Region

4.2 World Historic Tofacitinib Market Size by Country/Region (2017-2022)

4.2.1 Global Tofacitinib Annual Sales by Country/Region (2017-2022)

4.2.2 Global Tofacitinib Annual Revenue by Country/Region

4.3 Americas Tofacitinib Sales Growth

4.4 APAC Tofacitinib Sales Growth

4.5 Europe Tofacitinib Sales Growth

4.6 Middle East & Africa Tofacitinib Sales Growth

5 Americas

5.1 Americas Tofacitinib Sales by Country

5.1.1 Americas Tofacitinib Sales by Country (2017-2022)

5.1.2 Americas Tofacitinib Revenue by Country (2017-2022)

5.2 Americas Tofacitinib Sales by Type

5.3 Americas Tofacitinib Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Tofacitinib Sales by Region

6.1.1 APAC Tofacitinib Sales by Region (2017-2022)

6.1.2 APAC Tofacitinib Revenue by Region (2017-2022)

6.2 APAC Tofacitinib Sales by Type

6.3 APAC Tofacitinib Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Tofacitinib by Country

7.1.1 Europe Tofacitinib Sales by Country (2017-2022)

7.1.2 Europe Tofacitinib Revenue by Country (2017-2022)

7.2 Europe Tofacitinib Sales by Type

7.3 Europe Tofacitinib Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Tofacitinib by Country

8.1.1 Middle East & Africa Tofacitinib Sales by Country (2017-2022)

8.1.2 Middle East & Africa Tofacitinib Revenue by Country (2017-2022)

8.2 Middle East & Africa Tofacitinib Sales by Type

8.3 Middle East & Africa Tofacitinib Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Tofacitinib

10.3 Manufacturing Process Analysis of Tofacitinib

10.4 Industry Chain Structure of Tofacitinib

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Tofacitinib Distributors

11.3 Tofacitinib Customer

12 World Forecast Review for Tofacitinib by Geographic Region

12.1 Global Tofacitinib Market Size Forecast by Region

12.1.1 Global Tofacitinib Forecast by Region (2023-2028)

12.1.2 Global Tofacitinib Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Tofacitinib Forecast by Type

12.7 Global Tofacitinib Forecast by Application

13 Key Players Analysis

13.1 Pfizer

13.1.1 Pfizer Company Information

13.1.2 Pfizer Tofacitinib Product Offered

13.1.3 Pfizer Tofacitinib Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Pfizer Main Business Overview

13.1.5 Pfizer Latest Developments

13.2 Globe Pharmaceuticals

13.2.1 Globe Pharmaceuticals Company Information

13.2.2 Globe Pharmaceuticals Tofacitinib Product Offered

13.2.3 Globe Pharmaceuticals Tofacitinib Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Globe Pharmaceuticals Main Business Overview

13.2.5 Globe Pharmaceuticals Latest Developments

13.3 Delta Pharma Limited

13.3.1 Delta Pharma Limited Company Information

13.3.2 Delta Pharma Limited Tofacitinib Product Offered

13.3.3 Delta Pharma Limited Tofacitinib Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Delta Pharma Limited Main Business Overview

13.3.5 Delta Pharma Limited Latest Developments

13.4 Beacon Pharmaceuticals

13.4.1 Beacon Pharmaceuticals Company Information

13.4.2 Beacon Pharmaceuticals Tofacitinib Product Offered

13.4.3 Beacon Pharmaceuticals Tofacitinib Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Beacon Pharmaceuticals Main Business Overview

13.4.5 Beacon Pharmaceuticals Latest Developments

13.5 Drug International

13.5.1 Drug International Company Information

13.5.2 Drug International Tofacitinib Product Offered

13.5.3 Drug International Tofacitinib Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Drug International Main Business Overview

13.5.5 Drug International Latest Developments

14 Research Findings and Conclusion

Table 1. Tofacitinib Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Tofacitinib Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of 5mg*60 Tablets

Table 4. Major Players of 5mg*10 Tablets

Table 5. Major Players of 10mg*10 Tablets

Table 6. Major Players of 5mg*30 Tablets

Table 7. Major Players of 5mg*14 Tablets

Table 8. Major Players of 10mg*14 Tablets

Table 9. Global Tofacitinib Sales by Type (2017-2022) & (K Pcs)

Table 10. Global Tofacitinib Sales Market Share by Type (2017-2022)

Table 11. Global Tofacitinib Revenue by Type (2017-2022) & ($ million)

Table 12. Global Tofacitinib Revenue Market Share by Type (2017-2022)

Table 13. Global Tofacitinib Sale Price by Type (2017-2022) & (USD/Pcs)

Table 14. Global Tofacitinib Sales by Application (2017-2022) & (K Pcs)

Table 15. Global Tofacitinib Sales Market Share by Application (2017-2022)

Table 16. Global Tofacitinib Revenue by Application (2017-2022)

Table 17. Global Tofacitinib Revenue Market Share by Application (2017-2022)

Table 18. Global Tofacitinib Sale Price by Application (2017-2022) & (USD/Pcs)

Table 19. Global Tofacitinib Sales by Company (2020-2022) & (K Pcs)

Table 20. Global Tofacitinib Sales Market Share by Company (2020-2022)

Table 21. Global Tofacitinib Revenue by Company (2020-2022) ($ Millions)

Table 22. Global Tofacitinib Revenue Market Share by Company (2020-2022)

Table 23. Global Tofacitinib Sale Price by Company (2020-2022) & (USD/Pcs)

Table 24. Key Manufacturers Tofacitinib Producing Area Distribution and Sales Area

Table 25. Players Tofacitinib Products Offered

Table 26. Tofacitinib Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 27. New Products and Potential Entrants

Table 28. Mergers & Acquisitions, Expansion

Table 29. Global Tofacitinib Sales by Geographic Region (2017-2022) & (K Pcs)

Table 30. Global Tofacitinib Sales Market Share Geographic Region (2017-2022)

Table 31. Global Tofacitinib Revenue by Geographic Region (2017-2022) & ($ millions)

Table 32. Global Tofacitinib Revenue Market Share by Geographic Region (2017-2022)

Table 33. Global Tofacitinib Sales by Country/Region (2017-2022) & (K Pcs)

Table 34. Global Tofacitinib Sales Market Share by Country/Region (2017-2022)

Table 35. Global Tofacitinib Revenue by Country/Region (2017-2022) & ($ millions)

Table 36. Global Tofacitinib Revenue Market Share by Country/Region (2017-2022)

Table 37. Americas Tofacitinib Sales by Country (2017-2022) & (K Pcs)

Table 38. Americas Tofacitinib Sales Market Share by Country (2017-2022)

Table 39. Americas Tofacitinib Revenue by Country (2017-2022) & ($ Millions)

Table 40. Americas Tofacitinib Revenue Market Share by Country (2017-2022)

Table 41. Americas Tofacitinib Sales by Type (2017-2022) & (K Pcs)

Table 42. Americas Tofacitinib Sales Market Share by Type (2017-2022)

Table 43. Americas Tofacitinib Sales by Application (2017-2022) & (K Pcs)

Table 44. Americas Tofacitinib Sales Market Share by Application (2017-2022)

Table 45. APAC Tofacitinib Sales by Region (2017-2022) & (K Pcs)

Table 46. APAC Tofacitinib Sales Market Share by Region (2017-2022)

Table 47. APAC Tofacitinib Revenue by Region (2017-2022) & ($ Millions)

Table 48. APAC Tofacitinib Revenue Market Share by Region (2017-2022)

Table 49. APAC Tofacitinib Sales by Type (2017-2022) & (K Pcs)

Table 50. APAC Tofacitinib Sales Market Share by Type (2017-2022)

Table 51. APAC Tofacitinib Sales by Application (2017-2022) & (K Pcs)

Table 52. APAC Tofacitinib Sales Market Share by Application (2017-2022)

Table 53. Europe Tofacitinib Sales by Country (2017-2022) & (K Pcs)

Table 54. Europe Tofacitinib Sales Market Share by Country (2017-2022)

Table 55. Europe Tofacitinib Revenue by Country (2017-2022) & ($ Millions)

Table 56. Europe Tofacitinib Revenue Market Share by Country (2017-2022)

Table 57. Europe Tofacitinib Sales by Type (2017-2022) & (K Pcs)

Table 58. Europe Tofacitinib Sales Market Share by Type (2017-2022)

Table 59. Europe Tofacitinib Sales by Application (2017-2022) & (K Pcs)

Table 60. Europe Tofacitinib Sales Market Share by Application (2017-2022)

Table 61. Middle East & Africa Tofacitinib Sales by Country (2017-2022) & (K Pcs)

Table 62. Middle East & Africa Tofacitinib Sales Market Share by Country (2017-2022)

Table 63. Middle East & Africa Tofacitinib Revenue by Country (2017-2022) & ($ Millions)

Table 64. Middle East & Africa Tofacitinib Revenue Market Share by Country (2017-2022)

Table 65. Middle East & Africa Tofacitinib Sales by Type (2017-2022) & (K Pcs)

Table 66. Middle East & Africa Tofacitinib Sales Market Share by Type (2017-2022)

Table 67. Middle East & Africa Tofacitinib Sales by Application (2017-2022) & (K Pcs)

Table 68. Middle East & Africa Tofacitinib Sales Market Share by Application (2017-2022)

Table 69. Key Market Drivers & Growth Opportunities of Tofacitinib

Table 70. Key Market Challenges & Risks of Tofacitinib

Table 71. Key Industry Trends of Tofacitinib

Table 72. Tofacitinib Raw Material

Table 73. Key Suppliers of Raw Materials

Table 74. Tofacitinib Distributors List

Table 75. Tofacitinib Customer List

Table 76. Global Tofacitinib Sales Forecast by Region (2023-2028) & (K Pcs)

Table 77. Global Tofacitinib Sales Market Forecast by Region

Table 78. Global Tofacitinib Revenue Forecast by Region (2023-2028) & ($ millions)

Table 79. Global Tofacitinib Revenue Market Share Forecast by Region (2023-2028)

Table 80. Americas Tofacitinib Sales Forecast by Country (2023-2028) & (K Pcs)

Table 81. Americas Tofacitinib Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. APAC Tofacitinib Sales Forecast by Region (2023-2028) & (K Pcs)

Table 83. APAC Tofacitinib Revenue Forecast by Region (2023-2028) & ($ millions)

Table 84. Europe Tofacitinib Sales Forecast by Country (2023-2028) & (K Pcs)

Table 85. Europe Tofacitinib Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Middle East & Africa Tofacitinib Sales Forecast by Country (2023-2028) & (K Pcs)

Table 87. Middle East & Africa Tofacitinib Revenue Forecast by Country (2023-2028) & ($ millions)

Table 88. Global Tofacitinib Sales Forecast by Type (2023-2028) & (K Pcs)

Table 89. Global Tofacitinib Sales Market Share Forecast by Type (2023-2028)

Table 90. Global Tofacitinib Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 91. Global Tofacitinib Revenue Market Share Forecast by Type (2023-2028)

Table 92. Global Tofacitinib Sales Forecast by Application (2023-2028) & (K Pcs)

Table 93. Global Tofacitinib Sales Market Share Forecast by Application (2023-2028)

Table 94. Global Tofacitinib Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 95. Global Tofacitinib Revenue Market Share Forecast by Application (2023-2028)

Table 96. Pfizer Basic Information, Tofacitinib Manufacturing Base, Sales Area and Its Competitors

Table 97. Pfizer Tofacitinib Product Offered

Table 98. Pfizer Tofacitinib Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 99. Pfizer Main Business

Table 100. Pfizer Latest Developments

Table 101. Globe Pharmaceuticals Basic Information, Tofacitinib Manufacturing Base, Sales Area and Its Competitors

Table 102. Globe Pharmaceuticals Tofacitinib Product Offered

Table 103. Globe Pharmaceuticals Tofacitinib Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 104. Globe Pharmaceuticals Main Business

Table 105. Globe Pharmaceuticals Latest Developments

Table 106. Delta Pharma Limited Basic Information, Tofacitinib Manufacturing Base, Sales Area and Its Competitors

Table 107. Delta Pharma Limited Tofacitinib Product Offered

Table 108. Delta Pharma Limited Tofacitinib Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 109. Delta Pharma Limited Main Business

Table 110. Delta Pharma Limited Latest Developments

Table 111. Beacon Pharmaceuticals Basic Information, Tofacitinib Manufacturing Base, Sales Area and Its Competitors

Table 112. Beacon Pharmaceuticals Tofacitinib Product Offered

Table 113. Beacon Pharmaceuticals Tofacitinib Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 114. Beacon Pharmaceuticals Main Business

Table 115. Beacon Pharmaceuticals Latest Developments

Table 116. Drug International Basic Information, Tofacitinib Manufacturing Base, Sales Area and Its Competitors

Table 117. Drug International Tofacitinib Product Offered

Table 118. Drug International Tofacitinib Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 119. Drug International Main Business

Table 120. Drug International Latest Developments

List of Figures

Figure 1. Picture of Tofacitinib

Figure 2. Tofacitinib Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Tofacitinib Sales Growth Rate 2017-2028 (K Pcs)

Figure 7. Global Tofacitinib Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Tofacitinib Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of 5mg*60 Tablets

Figure 10. Product Picture of 5mg*10 Tablets

Figure 11. Product Picture of 10mg*10 Tablets

Figure 12. Product Picture of 5mg*30 Tablets

Figure 13. Product Picture of 5mg*14 Tablets

Figure 14. Product Picture of 10mg*14 Tablets

Figure 15. Global Tofacitinib Sales Market Share by Type in 2021

Figure 16. Global Tofacitinib Revenue Market Share by Type (2017-2022)

Figure 17. Tofacitinib Consumed in Rheumatoid Arthritis

Figure 18. Global Tofacitinib Market: Rheumatoid Arthritis (2017-2022) & (K Pcs)

Figure 19. Tofacitinib Consumed in Ulcerative Colitis

Figure 20. Global Tofacitinib Market: Ulcerative Colitis (2017-2022) & (K Pcs)

Figure 21. Tofacitinib Consumed in Psoriasis

Figure 22. Global Tofacitinib Market: Psoriasis (2017-2022) & (K Pcs)

Figure 23. Tofacitinib Consumed in Other

Figure 24. Global Tofacitinib Market: Other (2017-2022) & (K Pcs)

Figure 25. Global Tofacitinib Sales Market Share by Application (2017-2022)

Figure 26. Global Tofacitinib Revenue Market Share by Application in 2021

Figure 27. Tofacitinib Revenue Market by Company in 2021 ($ Million)

Figure 28. Global Tofacitinib Revenue Market Share by Company in 2021

Figure 29. Global Tofacitinib Sales Market Share by Geographic Region (2017-2022)

Figure 30. Global Tofacitinib Revenue Market Share by Geographic Region in 2021

Figure 31. Global Tofacitinib Sales Market Share by Region (2017-2022)

Figure 32. Global Tofacitinib Revenue Market Share by Country/Region in 2021

Figure 33. Americas Tofacitinib Sales 2017-2022 (K Pcs)

Figure 34. Americas Tofacitinib Revenue 2017-2022 ($ Millions)

Figure 35. APAC Tofacitinib Sales 2017-2022 (K Pcs)

Figure 36. APAC Tofacitinib Revenue 2017-2022 ($ Millions)

Figure 37. Europe Tofacitinib Sales 2017-2022 (K Pcs)

Figure 38. Europe Tofacitinib Revenue 2017-2022 ($ Millions)

Figure 39. Middle East & Africa Tofacitinib Sales 2017-2022 (K Pcs)

Figure 40. Middle East & Africa Tofacitinib Revenue 2017-2022 ($ Millions)

Figure 41. Americas Tofacitinib Sales Market Share by Country in 2021

Figure 42. Americas Tofacitinib Revenue Market Share by Country in 2021

Figure 43. United States Tofacitinib Revenue Growth 2017-2022 ($ Millions)

Figure 44. Canada Tofacitinib Revenue Growth 2017-2022 ($ Millions)

Figure 45. Mexico Tofacitinib Revenue Growth 2017-2022 ($ Millions)

Figure 46. Brazil Tofacitinib Revenue Growth 2017-2022 ($ Millions)

Figure 47. APAC Tofacitinib Sales Market Share by Region in 2021

Figure 48. APAC Tofacitinib Revenue Market Share by Regions in 2021

Figure 49. China Tofacitinib Revenue Growth 2017-2022 ($ Millions)

Figure 50. Japan Tofacitinib Revenue Growth 2017-2022 ($ Millions)

Figure 51. South Korea Tofacitinib Revenue Growth 2017-2022 ($ Millions)

Figure 52. Southeast Asia Tofacitinib Revenue Growth 2017-2022 ($ Millions)

Figure 53. India Tofacitinib Revenue Growth 2017-2022 ($ Millions)

Figure 54. Australia Tofacitinib Revenue Growth 2017-2022 ($ Millions)

Figure 55. Europe Tofacitinib Sales Market Share by Country in 2021

Figure 56. Europe Tofacitinib Revenue Market Share by Country in 2021

Figure 57. Germany Tofacitinib Revenue Growth 2017-2022 ($ Millions)

Figure 58. France Tofacitinib Revenue Growth 2017-2022 ($ Millions)

Figure 59. UK Tofacitinib Revenue Growth 2017-2022 ($ Millions)

Figure 60. Italy Tofacitinib Revenue Growth 2017-2022 ($ Millions)

Figure 61. Russia Tofacitinib Revenue Growth 2017-2022 ($ Millions)

Figure 62. Middle East & Africa Tofacitinib Sales Market Share by Country in 2021

Figure 63. Middle East & Africa Tofacitinib Revenue Market Share by Country in 2021

Figure 64. Egypt Tofacitinib Revenue Growth 2017-2022 ($ Millions)

Figure 65. South Africa Tofacitinib Revenue Growth 2017-2022 ($ Millions)

Figure 66. Israel Tofacitinib Revenue Growth 2017-2022 ($ Millions)

Figure 67. Turkey Tofacitinib Revenue Growth 2017-2022 ($ Millions)

Figure 68. GCC Country Tofacitinib Revenue Growth 2017-2022 ($ Millions)

Figure 69. Manufacturing Cost Structure Analysis of Tofacitinib in 2021

Figure 70. Manufacturing Process Analysis of Tofacitinib

Figure 71. Industry Chain Structure of Tofacitinib

Figure 72. Channels of Distribution

Figure 73. Distributors Profiles